Structural changes of the erythrocyte as a marker of non-insulin-dependent diabetes: protective effects of N-acetylcysteine

Biochem Biophys Res Commun. 2002 Feb 8;290(5):1393-8. doi: 10.1006/bbrc.2002.6340.

Abstract

Prooxidant-antioxidant imbalance was considered as a hallmark of age-associated, non-insulin-dependent diabetes (NIDD). The aim of this ex vivo study was to investigate possible implications of oxidative stress in the integrity and function of red blood cells (RBCs) from NIDD patients. Morphometric and analytical cytology studies were conducted. The results showed: (i) significant alterations of RBC ultrastructure; (ii) relevant changes of spectrin cytoskeleton; (iii) altered insulin receptor distribution; and (iv) that treatment with the antioxidizing drug N-acetylcysteine was capable of significantly counteracting these changes. These results suggest a reconsideration of RBC integrity as a possible progression marker in NIDD.

MeSH terms

  • Acanthocytes / drug effects
  • Acanthocytes / ultrastructure
  • Acetylcysteine / administration & dosage
  • Acetylcysteine / pharmacology*
  • Aged
  • Aged, 80 and over
  • Antioxidants / administration & dosage
  • Antioxidants / pharmacology*
  • Cell Size / drug effects
  • Cytoskeleton / drug effects
  • Cytoskeleton / ultrastructure
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / pathology
  • Disease Progression
  • Erythrocyte Membrane / drug effects
  • Erythrocyte Membrane / metabolism
  • Erythrocyte Membrane / ultrastructure
  • Erythrocytes / drug effects*
  • Erythrocytes / metabolism
  • Erythrocytes / ultrastructure*
  • Female
  • Glutathione / blood
  • Humans
  • Microscopy, Electron, Scanning
  • Receptor, Insulin / analysis
  • Spectrin / analysis

Substances

  • Antioxidants
  • Spectrin
  • Receptor, Insulin
  • Glutathione
  • Acetylcysteine